Tau pathology and acetylcholinesterase-inhibitor treatment is related to parietal lobe function in Alzheimer's disease

被引：0
|
作者：
Minthon, L
Ericson, C
Warkentin, S
Blennow, K
机构：
[1] Neuropsychiat Clin, Malmo, Sweden
[2] Inst Clin Sci, Gothenburg, Sweden
来源：
NEUROBIOLOGY OF AGING | 2002年 / 23卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
1353
引用
收藏
页码：S369 / S369
页数：1
相关论文
共 50 条
  • [31] Cerebral metabolic response to acetylcholinesterase inhibitor treatment in patients with Alzheimer's disease
    Mega, MS
    ANNALS OF NEUROLOGY, 2002, 52 (03) : S70 - S70
  • [32] Development of Reminyl® (galantamine), a novel acetylcholinesterase inhibitor, for the treatment of Alzheimer's disease
    Parys, W
    ALZHEIMERS REPORTS, 1998, 1 : S19 - S20
  • [33] Computerized cognition assessment during acetylcholinesterase inhibitor treatment in Alzheimer's disease
    Wesnes, K.
    Edgar, C.
    Andreasen, N.
    Annas, P.
    Basun, H.
    Lannfelt, L.
    Zetterberg, H.
    Blennow, K.
    Minthon, L.
    ACTA NEUROLOGICA SCANDINAVICA, 2010, 122 (04): : 270 - 277
  • [34] Rivastigmine: An acetylcholinesterase inhibitor for patients with Alzheimer's disease
    White, CM
    Dicks, RS
    FORMULARY, 1999, 34 (06) : 493 - +
  • [35] Alzheimer's disease with asymmetric parietal lobe atrophy: A case report
    Kaida, K
    Takeda, K
    Nagata, N
    Kamakura, K
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1998, 160 (01) : 96 - 99
  • [36] Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study
    Shi-Dong Chen
    Jia-Ying Lu
    Hong-Qi Li
    Yu-Xiang Yang
    Jie-Hui Jiang
    Mei Cui
    Chuan-Tao Zuo
    Lan Tan
    Qiang Dong
    Jin-Tai Yu
    Translational Psychiatry, 11
  • [37] Staging tau pathology with tau PET in Alzheimer's disease: a longitudinal study
    Chen, Shi-Dong
    Lu, Jia-Ying
    Li, Hong-Qi
    Yang, Yu-Xiang
    Jiang, Jie-Hui
    Cui, Mei
    Zuo, Chuan-Tao
    Tan, Lan
    Dong, Qiang
    Yu, Jin-Tai
    TRANSLATIONAL PSYCHIATRY, 2021, 11 (01)
  • [38] Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement
    Ossenkoppele, Rik
    Zwan, Marissa D.
    Tolboom, Nelleke
    van Assema, Danielle M. E.
    Adriaanse, Sofie F.
    Kloet, Reina W.
    Boellaard, Ronald
    Windhorst, Albert D.
    Barkhof, Frederik
    Lammertsma, Adriaan A.
    Scheltens, Philip
    van der Flier, Wiesje M.
    van Berckel, Bart N. M.
    BRAIN, 2012, 135 : 2115 - 2125
  • [39] Treatment of Alzheimer's Disease by acetylcholinesterase inhibitors
    Dartigues, J. -F.
    Poncet, M.
    REVUE NEUROLOGIQUE, 2008, 164 : F107 - F107
  • [40] Abnormalities of acetylcholinesterase in Alzheimer's disease with special reference to effect of acetylcholinesterase inhibitor
    Mimori, Y
    Nakamura, S
    Yukawa, M
    BEHAVIOURAL BRAIN RESEARCH, 1997, 83 (1-2) : 25 - 30
12345